Global Embolotherapy Market 2021
- बाज़ार रिपोर्ट
- पहचान: HL22896G
- डिलीवरी का समय: 1 दिन के कारोबार
- टैग: Embolotherapy
विवरण
Embolotherapy is a type of endovascular treatment that aims to occlude abnormal blood vessels in order to control bleeding, close fistulae or arteriovenous malformations, devascularise organs, reduce tumours and much more. To accomplish occlusion, embolotherapy uses minimally-invasive techniques and various embolic agents, such as gelfoam, coils, balloons and angiographic catheters to achieve precise and significant results. The global embolotherapy market is set to grow by US$ 1.50 के दौरान अरब 2021-2027, growing at a compound annual growth rate (सीएजीआर) का 6.6% पूर्वानुमान अवधि के दौरान, डेटा और एनालिटिक्स कंपनी स्ट्रैटेजीहेलिक्स के अनुसार. Growing target population, expanding applications of embolotherapy devices, escalating prevalence of chronic and lifestyle-associated diseases, increasing healthcare expenditure, and improving healthcare infrastructure are expected to boost the market growth in the coming years.
रिपोर्ट अवधि के लिए नवीनतम बाज़ार आकार डेटा प्रदान करती है 2017-2020 और पूर्वानुमान करें 2027 covering key market aspects like sales value for embolotherapy. The global embolotherapy market is segmented on the basis of product, indication, procedure, region, and end user. उत्पाद द्वारा, it is categorized into embolic agents, and support devices. The embolic agents segment held the largest market share in 2020. By indication, the embolotherapy market is divided into cancer, neurological diseases, peripheral vascular diseases, urological and nephrological disorders, and gastrointestinal disorders. The cancer segment accounted for the largest market share in 2020. Based on procedure, the embolotherapy market is divided into transcatheter arterial embolization, transarterial chemoembolization, and transarterial radioembolization/selective internal radiation therapy. Embolotherapy market by region is divided into North America, एशिया प्रशांत, यूरोप, and Rest of the World (ROW).
The report has profiled some of the key players of the market such as Acandis GmbH, Balt Extrusion SAS, Boston Scientific Corporation, Cook Group Incorporated, Guerbet SA, Johnson & Johnson, Kaneka Corporation, Medtronic plc, Meril Life Sciences Private Limited, Merit Medical Systems Inc., Penumbra Inc., Sirtex Medical Limited, Stryker Corporation, Terumo Corporation.
यह रिपोर्ट इस उद्योग में सक्रिय कंपनियों और संगठनों के लिए एक अमूल्य संसाधन है. It provides a cohesive picture of the embolotherapy market to help drive informed decision making for industry executives, नीति निर्माताओं, अकादमिक, और विश्लेषक.
रिपोर्ट का दायरा
उत्पाद: embolic agents, and support devices
Indication: cancer, neurological diseases, peripheral vascular diseases, urological and nephrological disorders, and gastrointestinal disorders
Procedure: transcatheter arterial embolization, transarterial chemoembolization, and transarterial radioembolization/selective internal radiation therapy
End user: hospitals and clinics, ambulatory surgical centers (ascs), और दूसरे
क्षेत्र: उत्तरी अमेरिका, एशिया प्रशांत, यूरोप, and Rest of the World (ROW)
वर्षों पर विचार किया गया: यह रिपोर्ट उस अवधि को कवर करती है 2017 को 2027
हितधारकों के लिए मुख्य लाभ
Get a comprehensive picture of the global embolotherapy market
Identify regional strategies and strategic priorities on the basis of local data and analysis
विकास क्षेत्रों और निवेश के रुझानों को इंगित करें
Understand what the future of the global embolotherapy market looks like
प्रतिस्पर्धी परिदृश्य और अवसर की खिड़की की पहचान करें
विषयसूची
1. बाज़ार परिभाषा
2. अनुसंधान क्रियाविधि
3. बाजार के आंकड़े & आउटलुक
3.1 बाजार मूल्य
3.2 बाज़ार मूल्य का पूर्वानुमान
4. Embolotherapy Market by Product
4.1 Embolic Agents
4.2 Support Devices
5. Embolotherapy Market by Indication
5.1 Cancer
5.2 Neurological Diseases
5.3 Peripheral Vascular Diseases
5.4 Urological And Nephrological Disorders
5.5 Gastrointestinal Disorders
6. Embolotherapy Market by Procedure
6.1 Transcatheter Arterial Embolization
6.2 Transarterial Chemoembolization
6.3 Transarterial Radioembolization/Selective Internal Radiation Therapy
7. Embolotherapy Market by Region
7.1 उत्तरी अमेरिका
7.2 एशिया प्रशांत
7.3 यूरोप
7.4 Rest Of The World (Row)
8. Embolotherapy Market by End User
8.1 Hospitals And Clinics
8.2 Ambulatory Surgical Centers (Ascs)
8.3 अन्य
9. कंपनी प्रोफाइल
9.1 Acandis GmbH
9.2 Balt Extrusion SAS
9.3 Boston Scientific Corporation
9.4 Cook Group Incorporated
9.5 Guerbet SA
9.6 Johnson & Johnson
9.7 Kaneka Corporation
9.8 Medtronic plc
9.9 Meril Life Sciences Private Limited
9.10 Merit Medical Systems Inc.
9.11 Penumbra, इंक.
9.12 Sirtex Medical Limited
9.13 Stryker Corporation
9.14 Terumo Corporation
10. अनुबंध
10.1 स्ट्रेटेजीहेलिक्स के बारे में
10.2 अस्वीकरण
USD 2,750